Login
PMGC Holdings Inc logo

PMGC Holdings Inc

pmgcholdings.com

What Do They Do?

Develops biotechnology assets, invests in businesses, and supplies specialty packaging and precision-machined parts to technology, aerospace and industrial customers.

How Do They Make Money?

Customers pay for IT packaging and completed machined parts under purchase orders, generally within 30 to 60 days; payment is due when goods ship or, in some cases, are delivered.

FY2025 revenue

Who Are Their Customers?

OEMs and contract manufacturers buy packaging primarily through Pacific Sun's direct sales force; AGA serves aerospace, defense and industrial customers.

Customers above 10% of revenue, FY2025
of revenue from one customer

Do Revenues Turn Into Profits?

No. It lost $7.7M in FY2025.

Operating income, FY2025
−1166% of revenue
Net income, FY2025
−1313% of revenue
Free cash flow, FY2025
−1081% of revenue

How Are They Changing?

Since the FY2025 annual report
Latest quarter: Q2 FY2026, the three months to Jun 30, 2026
Revenue
Net income
▲ +423% (Loss)
vs −$562.4K in Q2 FY2025
  • Sep 2, 2026 NorthStrive expands its YuvaBio drug-development program The amendment launches an expanded program for compounds in cardiac diseases and obesity.
  • Jul 7, 2026 NorthStrive Defense Tech obtains an exclusive aerospace and defense license The license covers development and commercialization of licensed products in aerospace and defense technologies.
  • May 13, 2026 PMGC acquires A&B Aerospace The acquisition adds A&B Aerospace, a precision-machining business, to PMGC's portfolio.

Who Do They Compete With?

Competes with Novo Nordisk, Eli Lilly, Pfizer, Biohaven, Scholar Rock, and Veru

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support